Julie Ehlers

Researchers have identified more than 275 million previously unreported genetic variants via the All of Us Research Program.

Several corrections have been made to study reports written by researchers at the Dana-Farber Cancer Institute since errors in these and other papers were the topic of controversy last month.

Belantamab mafodotin plus bortezomib and dexamethasone could be a new standard of care for second-line or later treatment of relapsed or refractory multiple myeloma, according to researchers.

US cancer incidence and mortality rates have decreased in recent years, according to the American Cancer Society’s latest report on cancer statistics.

Researchers have linked genomic data and clinical data to identify genes that affect prognosis in cancer patients.

Adding atezolizumab to treatment with carboplatin improved survival outcomes in patients with metastatic TNBC in a phase 2 trial.

Patients with gastric cancer have better outcomes of immune checkpoint inhibitor treatment if they have a high tumor mutational burden, a meta-analysis suggests.

ASCO has released guidelines on how to treat patients amid current cancer drug shortages.

New research suggests that, in the United States, the use of palliative care for metastatic breast cancer varies by race.

AI chatbots can sometimes provide accurate information about cancers, but these tools have significant limitations, according to researchers.